overgrowth
- 12 May 2005 22:21
Mediwatch is a small
company destined to become a much bigger fish by the time this year is
out.
Mediwatch are already a market leader in urological medical diagnostics
equipement and are currently exporting their products throughout the UK,
Canada, Europe, India and Japan.
That doesn't leave much of the globe left for them to capture - until
you remember the good ol' US and China.
These are the two massive markets which are destined to be added to MDW's
export client portfolio by the end of 2005.
|
|
The company is currently
heavily undervalued. This is probably because Mediwatch's speciality is
not a very glamourous business to be in as their equipment is used extensively
to diagnose prostate cancer in men and other nasty urological conditions
affecting both men and women. However, don't let that put you off investing
in these guys. This is big business and is growing at an exponential rate
as more and more people globally become health-aware as they get older.
Mediwatch normally
supply their products through to global markets via distribution agreements.
They already have the best of distribution partners in the well known
US medical distributor CR Bard who supply Canada and Europe and GE Medical
who supply Japan. The UK business is handled by Mediwatch's own dedicated
sales team.
US FDA approval was
gained for MDW's products at the start of last year, however a whole year
of US legal wrangling meant that they were unable to seek a suitable partner
for the crucial distribution agreement until the start of this year. This
distribution agreement is expected by the board to have a "significant
effect" on the share price so they are reluctant to give any clues
as to when it will be signed, sealed and delivered. The general consensus
is that this US distribution agreement will be announced in July/August.
In China and Hong Kong, MDW have done things the other way round. They
have set up distribution agreements with major Asian medical equipment
distributors and have stock already out there waiting to sell into the
markets - all they are waiting for is SDA approval (which is a "rubber
stamp") from the Chinese authorities - this can take anything up
to 12 months to come through and MDW applied during Autumn 2004 - so even
more good news coming soon this year.
Epidemiological data from British Association of Urology conference last year: On average 30-45% of all men between the age of 50 and 70 have at least one PSA test per year in the US / Italy / Australia.
If that's not enough
to convince you to invest a few hard earned coppers in MDW, they are also
developing a PSA stick test product (PSAWatch) which is revolutionary and causing
some excitement in medical circles. This product can also be adapted (at
very low cost) for a whole spectrum of medical disciplines from Cardiology
to Veterinary Practice! This product is likely to be released in the next
few weeks. Philip Stimpson the CEO has said that this product is going
to be their "gold mine" - I'm sure it will prove to be ours
too.
|

ptholden
- 13 Jul 2005 08:35
- 470 of 1497
strong start to the day
pth
banjomick
- 13 Jul 2005 18:11
- 471 of 1497
Don't know if these articles have been posted here so apologies if it's old news!
http://www.ukhealthmatters.com/inbrief/inbrief_index.htm
http://www.mlwmagazine.com/story.asp?sectionCode=201&storyCode=2029509
banjomick
- 13 Jul 2005 23:49
- 472 of 1497
the ukhealthmatters website appears to be closed down at the moment??
The MLW is ok though and coppied it below.The UKHealth site gave an even more positive writeup.
Portable detection of prostate cancer
01 July 2005
The time taken to deliver prostate disease results to GPs, hospital doctors and patients, could be reduced from weeks to minutes, through the use of PSAwatch, a new medical test from Mediwatch.
The test, profiled at the annual meeting of the British Urological Association of Surgeons in Glasgow on 29 June, detects prostate specific antigen (PSA) but uses a technique which enables it to be performed on a small portable machine called the BioScan, rather than on large laboratory equipment.
PSAwatch is comprised of a porous cellulose membrane impregnated with monoclonal anti-PSA antibodies and gold sol, housed in a plastic cassette. The test strip has three working zones referred to as the application, results and overflow zones. An absorbent blood separation pad lies within cassette beneath the sample application hole and contains gold sol labelled with monoclonal antibodies directed against PSA in the application zone. Addition of patient sample to this pad causes the gold sol to be resuspended and, if PSA is present in the sample, to react with the PSA and form a complex.
Mediwatch CEO Philip Stimpson says: Swift early diagnosis is an essential component for the successful treatment of many prostate diseases, especially prostate cancer. We believe our new test will prove invaluable both for clinicians and GPs but most of all for patients who, until now, have had to endure the agony of a one to two week wait before receiving their results.
The BioScan device costs approximately 900, with each PSAwatch stick (complete with reagents to perform assay) will cost approximately 3.50, and minimal training required by healthcare staff.
banjomick
- 15 Jul 2005 12:17
- 473 of 1497
Looks good!
ptholden
- 15 Jul 2005 15:05
- 475 of 1497
I agree OG, plenty of legs left in the TA, particularly the MACD. Need to get over recent resistance at 13.5p though. Wonder if it will make it at the first time of trying?
pth
jnknill
- 15 Jul 2005 15:10
- 476 of 1497
pth, Do think this is an "UP & DOWNER" by the MM,s to try and fill an order or does someone know something re Medtronic? Pick your brain please! Rgds.
ptholden
- 15 Jul 2005 15:26
- 477 of 1497
jnk
Only a few brain cells to pick at the moment. Sitting on a few real win situations, including this one.
For what it's worth, MDW is a tightly held stock, insomuch that there are so few issued shares for a small cap, so any buying (even relatively small) will generally result in the SP moving up, which is what's happening today (and yesterday). I don't think there are any leaks with regard to the Medtronic deal, if that were the case we would be seeing much larger trades zipping through. I suspect that the reason PIs are now getting back in is part of the natural cycle. The share was previously oversold and had fallen back to support at 10.5p. Becuase the upside is so good the buyers have come back in. I hadn't noticed today that the SP made a double bottom recently, which usually heralds the start of a new leg up (most unobservant of me). So, no, I don't think this has anything to do with MMs per se. However unless we can get through the resistance at 13.5p, it will fall back again, but this time to a higher low. Having said that, there would appear to be enough legs left to carry it through.
pth
jnknill
- 15 Jul 2005 15:43
- 478 of 1497
pth, Thanks for the info. Apart from my core holding I have held a percentage to trade, if I wished, but truthfully with all the potentials that have materialised I think that it would be better long term to treat them all as "core". They certainly wont see that price again! Glad your picture has turned north now, reckon you deserve that for patience(bloodimindiness!!)? Have a good weekend, presume some "Open" will take your time! Rgds.
ptholden
- 15 Jul 2005 15:56
- 479 of 1497
Always a pleasure Jnk. Watching the Open between playing golf and trying to make some sense of the Stock market. I was 95% (and still am) confident that MDW will come good. To be honest if the quantity of shares I held previously had been held in my Nominee account rather than CFDs I wouldn't have sold. But CFDs are a different ball game with much higher risks (and profits!). Feel much more comfortable now with only just a few less but at a much better average. Still learning and probably always will be.
have a nice weekend, let's hope we can hang onto this rise today and go even better next week.
pth
jnknill
- 15 Jul 2005 16:09
- 480 of 1497
pth, As soon as that 20k sell went through, the MM,s dropped thr price! Does that say anything to you? Rgds.
ptholden
- 15 Jul 2005 16:19
- 481 of 1497
jnk.
No. The time to wonder what is going on, is when there appear to be buys and the SP falls and then with sells, the SP rises.
Since you posted a 50k sell has gone through causing the same effect. The MMs will usually drop the SP on sells until the price appears no longer attractive to sellers, but more attractive to buyers. At this point, the buyers should come back in. If they don't it is likely that the MM will mark down the SP further until they do. All quite normal (tell me if I'm teaching you such eggs here Jnk!).
pth
rodspotty
- 15 Jul 2005 16:38
- 482 of 1497
All it says is buy order filled, 250K T trade at close. DYOR
Rodders
jnknill
- 15 Jul 2005 16:39
- 483 of 1497
pth, Thought the MM,s were, earlier on, trying to fill an order but when just "buys" occurred............? Rgds
ptholden
- 15 Jul 2005 16:41
- 484 of 1497
jnk
Yep you were right a 250k Buy just gone through, perhaps there has been a leak afterall, or is it just wishful thinking?
pth
rodspotty
- 18 Jul 2005 13:07
- 485 of 1497
Following on from Friday, another strong performance in the sp. DYOR
Rodders
overgrowth
- 18 Jul 2005 16:26
- 486 of 1497
jnk, you'll find this post very interesting if you're not a visitor to the advfn boards:
"Here's just a quick note about the BAUS conference. At the end of the conference one of the senior figures in urology - the professor of Urology at the Institute of Urology (based at UCH) gives a talk called 'the best of BAUS'. It is a slightly lighthearted talk, but one in which he highlights those talks / posters / presentations which he thought were most interesting / important etc. It is of course an entirely personal view, but from a very wise old bird. One of the things he highlighted was the PSA sticks - and the prospect of instant PSA. Very interesting!
If I was the chief exec I would be aiming to hit the GP market hard. Of course the hospital uology service is going to be the first target - but don't forget that the main source of our referrals is from GPs who have already checked a man's PSA in the community. Most men who are discovered to have prostate cancer have their first PSa in the community. 'Dear Doctor, This man's PSA is 6.7....' is a standard and very common referral letter. And of course there are MILLIONS more GPs than urologists.
I am convinced that the PSA testing sticks are a major step forward in terms of urological diagnostics, and from a purely financial point of view - this is one of those rare genuine 'first in its field' kind of discoveries which has a HUGE impact on the company who invented it.
Here's another thought. There are quite a lot of tumour markers used in medicine, such as CA-125 for ovarian cancer, CEA for colorectal cancer, CA15-3 for breast cancer, CA19-9 for pancreatic cancer - I could go on. The great thing about the testing sticks is that they require an antibody to the marker - and then the rest is the same. all of these tumour markers have commercially available antibodies - that's how they are measured now - but like PSA it takes best part of a week to get the result back. I spoke to one of the science bods at MDW on the BAUS conference and they are already looking into this. I imagine that in X years time, you will be able to buy a machine and then order strips for whatever tumour marker you want - or even have a multi stick which will test for several things at hte same time. **** me!!!!
Ooh - next patient has arrived. Must go!"
jnknill
- 18 Jul 2005 16:45
- 487 of 1497
OG, Many thanks for the above, obviously posted by a well-qualified individual and very,very interesting! The more that information of this calibre pops-up then the more one feels that the long term investment in MDW is a "winner", certainly the scope that PSA potentially has. Appreciated OG. Rgds.
rodspotty
- 18 Jul 2005 16:52
- 488 of 1497
Another day another 200K T trade buy filled, interesting. DYOR
Rodders
rodspotty
- 19 Jul 2005 11:23
- 489 of 1497
EVO's still out on the bid and looking for stock. DYOR
Rodders